Clinical Trial Update: Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

View source ↗

Summary

A completed trial evaluating the efficacy and safety of dihydroartemisinin-piperaquine for treating uncomplicated malaria caused by Plasmodium falciparum and Pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Plasmodium Falciparum Infection, Plasmodium Vivax Infection | Status: COMPLETED